Cite
MLA Citation
Youjin Kim et al.. “Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14‐01).” Cancer, vol. 123, no. 11, 2017, pp. 1958–1964. http://access.bl.uk/ark:/81055/vdc_100046383496.0x00005b